Your email has been successfully added to our mailing list.

×
0.0706638115631692 0.0706638115631692 0.094218415417559 0.0706638115631692 0.0513918629550322 0.074946466809422 0.0984796573875803 0.0599571734475375
Stock impact report

Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Purified Cannabidiol

Zynerba Pharmaceuticals (ZYNE)  More Company Research Source: GlobeNewswire
Last zynerba pharmaceuticals earnings: 3/10 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: ir.zynerba.com
PDF DEVON, Pa., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,568,848, titled “Treatment of Autism with Cannabidiol” which includes claims directed to methods of treating autism spectrum disorder (ASD) by transdermally administering, via a gel or cream, a therapeutically effective amount of purified cannabidiol (CBD). This new patent, which expires in 2038, is part of an expanding intellectual property portfolio covering the Company's transdermal cannabidiol product candidate, Zygel™ CBD gel. This patent follows the previously announced issuance of US Patent No. 10,314,792, titled “Treatment of Autism with Cannabidiol” which includes claims directed to methods of treating ASD by transdermally administering, via gel or cream, a ther [Read more]
Impact snapshot Event time: ZYNE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ZYNE alerts
from News Quantified
Opt-in for
ZYNE alerts

from News Quantified
Opt-in for
ZYNE alerts

from News Quantified